Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma

Hiroki Ishihara(Tokyo Women's Medical University), Toshio Takagi(Tokyo Women's Medical University), Hidekazu Tachibana, Hirohito Kobayashi(Ebina General Hospital), Kazuhiko Yoshida(Tokyo Women's Medical University Hospital), Hironori Fukuda(Tokyo Women's Medical University), Kazutaka Nakamura(Tokyo Women's Medical University Hospital), Yasunobu Hashimoto, Yuki Nemoto(Tokyo Women's Medical University Adachi Medical Center), Tsunenori Kondo(Tokyo Women's Medical University Adachi Medical Center), Hiroaki Shimmura(Jyoban Hospital of Tokiwa Foundation), Junpei Iizuka(Tokyo Women's Medical University), Kazunari Tanabe(Shonan Kamakura General Hospital)
Japanese Journal of Clinical Oncology
September 7, 2021
Cited by 15


Related Papers